Showing results (881-890 of 5,983) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|June 11, 2009
Simultaneous blockade of the epidermal growth factor receptor/mammalian target of rapamycin pathway by epidermal growth factor receptor inhibitors and rapamycin results in reduced cell growth and survival in biliary tract cancer cellsBeata Herberger, Walter Berger, Harald Puhalla, et al.
Molecular Cancer Therapeutics|June 11, 2009
Orally active alpha-tocopheryloxyacetic acid suppresses tumor growth and multiplicity of spontaneous murine breast cancerTobias Hahn, Karen Fried, Laurence H Hurley, et al.
Molecular Cancer Therapeutics|June 11, 2009
The Pyk2 FERM domain as a target to inhibit glioma migrationJoseph C Loftus, Zhongbo Yang, Nhan L Tran, et al.
Molecular Cancer Therapeutics|June 11, 2009
Luteinizing hormone-releasing hormone receptor-targeted deslorelin-docetaxel conjugate enhances efficacy of docetaxel in prostate cancer therapySneha Sundaram, Chandrasekar Durairaj, Rajendra Kadam, et al.
Molecular Cancer Therapeutics|June 11, 2009
Silibinin inhibits translation initiation: implications for anticancer therapyChen-Ju Lin, Rami Sukarieh, Jerry Pelletier
Molecular Cancer Therapeutics|June 11, 2009
Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathwayKenneth Thress, Terry Macintyre, Haiyun Wang, et al.
Molecular Cancer Therapeutics|June 11, 2009
Preclinical evaluation of a novel pyrimidopyrimidine for the prevention of nucleoside and nucleobase reversal of antifolate cytotoxicityHuw D Thomas, Kappusamy Saravanan, Lan-Zhen Wang, et al.
Molecular Cancer Therapeutics|June 11, 2009
Effect of autophagy on multiple myeloma cell viabilityBao Hoang, Angelica Benavides, Yijiang Shi, et al.
Molecular Cancer Therapeutics|May 7, 2009
Transcriptional induction of GRP78/BiP by histone deacetylase inhibitors and resistance to histone deacetylase inhibitor-induced apoptosisPeter Baumeister, Dezheng Dong, Yong Fu, et al.
Molecular Cancer Therapeutics|May 7, 2009
Amino acid containing thapsigargin analogues deplete androgen receptor protein via synthesis inhibition and induce the death of prostate cancer cellsDonald J Vander Griend, Lizamma Antony, Susan L Dalrymple, et al.
Pageof 599